Cargando…

An inventory of European data sources for the long-term safety evaluation of methylphenidate

To compile an inventory of European healthcare databases with potential to study long-term effects of methylphenidate (MPH) in patients with attention deficit hyperactivity disorder (ADHD). Potential databases were identified through expert opinion, the website of the European Network of Centres for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Macey L., Insuk, Suppachai, Banaschewski, Tobias, Neubert, Antje C., McCarthy, Suzanne, Buitelaar, Jan K., Coghill, David, Dittmann, Ralf W., Konrad, Kerstin, Panei, Pietro, Rosenthal, Eric, Sonuga-Barke, Edmund J., Wong, Ian C. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2013
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830128/ https://www.ncbi.nlm.nih.gov/pubmed/23508655 http://dx.doi.org/10.1007/s00787-013-0386-x

Ejemplares similares

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
por: Inglis, S K, et al.
Publicado: (2016)

Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)
por: McCarthy, Suzanne, et al.
Publicado: (2018)

European guidelines on managing adverse effects of medication for ADHD
por: Graham, J., et al.
Publicado: (2010)

Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system
por: Man, K K C, et al.
Publicado: (2016)

Differential utility of teacher and parent–teacher combined information in the assessment of Attention Deficit/Hyperactivity Disorder symptoms
por: Garcia-Rosales, Alexandra, et al.
Publicado: (2020)

Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data
por: Sonuga-Barke, Edmund JS, et al.
Publicado: (2004)

Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010)

Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale
por: Kovshoff, Hanna, et al.
Publicado: (2016)

The impact of ADHD on the health and well-being of ADHD children and their siblings
por: Peasgood, Tessa, et al.
Publicado: (2016)

Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries
por: Nafees, Beenish, et al.
Publicado: (2014)

Methylphenidate-Related Improvements in Math Performance Cannot Be Explained by Better Cognitive Functioning or Higher Academic Motivation: Evidence From a Randomized Controlled Trial
por: Kortekaas-Rijlaarsdam, Anne Fleur, et al.
Publicado: (2017)

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
por: Danckaerts, Marina, et al.
Publicado: (2009)

Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
por: Nagy, Peter, et al.
Publicado: (2015)

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
por: Coghill, David R., et al.
Publicado: (2013)

Editorial: Attention and Methylphenidate
por: Avital, Avi, et al.
Publicado: (2020)

Sex differences in risk-based decision making in adolescents with conduct disorder
por: Sidlauskaite, Justina, et al.
Publicado: (2017)

Preschool hyperactivity specifically elevates long-term mental health risks more strongly in males than females: a prospective longitudinal study through to young adulthood
por: Smith, Elizabeth, et al.
Publicado: (2016)

Erratum to: Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010)

Barriers to, and facilitators of, parenting programmes for childhood behaviour problems: a qualitative synthesis of studies of parents’ and professionals’ perceptions
por: Koerting, J., et al.
Publicado: (2013)

Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2013)

Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges
por: Glennon, Jeffrey, et al.
Publicado: (2013)

Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2015)

On the Reorganization of Incentive Structure to Promote Delay Tolerance: A Therapeutic Possibility for AD/HD?
por: Sonuga-Barke, Edmund J. S.
Publicado: (2004)

‘If it don't fit, don't force it?’ If real‐world, complex clinical decisions are intrinsically categorical can dimensional systems add value? Reflections on Lahey, Tiemeier & Krueger (2022)
por: Sonuga‐Barke, Edmund J. S.
Publicado: (2022)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years
por: Sonuga-Barke, Edmund J. S., et al.
Publicado: (2017)

Development and psychometric properties of the “Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales” in adolescents
por: Rodríguez-Quiroga, A., et al.
Publicado: (2019)

Clinical, Experimental, and Modeling Studies in AD/HD
por: Sonuga-Barke, Edmund J. S., et al.
Publicado: (2004)

DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics
por: Turic, Darko, et al.
Publicado: (2010)

Attention-Induced Deactivations in Very Low Frequency EEG Oscillations: Differential Localisation According to ADHD Symptom Status
por: Broyd, Samantha J., et al.
Publicado: (2011)

Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials
por: Cortese, Samuele, et al.
Publicado: (2015)

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults
por: Katzman, Martin A., et al.
Publicado: (2020)

First Inventory of Access and Quality of Metabolic Surgery Across Europe
por: Sinclair, Piriyah, et al.
Publicado: (2021)

More to ADHD than meets the eye: Observable abnormalities in search behaviour do not account for performance deficits on a discrimination task
por: Sonuga-Barke, Edmund JS, et al.
Publicado: (2005)

Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder
por: Gomeni, Roberto, et al.
Publicado: (2020)

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
por: Hodgkins, Paul, et al.
Publicado: (2012)

Distinguishing low frequency oscillations within the 1/f spectral behaviour of electromagnetic brain signals
por: Demanuele, Charmaine, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5m4vasn5mat5pchpe50htfd0g4